The purpose of this study was to assess the impact of body mass index (BMI) and diabetes mellitus (DM) on angiographic outcomes in patients treated with different drug-eluting stents. Methods: From November 2002 to March 2011, 8567 de novo coronary lesions were treated with drug-eluting stent. Dialysis patients were excluded. Of 8567 lesions, 1934 lesions were treated with everolimus-eluting stent (EES), 1215 with paclitaxel-eluting stent (PES), and 5418 with sirolimus-eluting stent (SES). Angiographic follow-up was routinely performed at 8 months after successful procedure. The follow-up rate was 81%. The patients were classified as underweight (BMI Ͼ20), normal weight (BMI Ն20 and Ͼ25), and overweight (BMI Ն25). The patients were divided into three groups according to implanted stent type: EES, PES, and SES. Of all patients, 42% were with DM, of whom 11% were insulin-dependent. The rates of DM and insulin treatment were similar in all groups. Angiographic outcomes were compared between each group. Results: Independent predictors of binary restenosis differed in each group. In the SES group, they were BMI (depression of 5 kg/m2), DM, bifurcation, chronic total obstruction (CTO), stent size 2.5 mm, and lesion length Ն20 mm. In the PES group, they were BMI (depression of 5 kg/m2), DM, and stent size 2.5 mm. In the EES group, they were CTO, stent size 2.5 mm, and lesion length Ն20 mm. The figure shows odds ratio of BMI (depression of 5 kg/m2) and DM between each group.
